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Summary.-Antibody-dependent cellular cytotoxicity ("killer" (K) cell activity) of
peripheral-blood lymphomononuclear (LMN) cells was determined in patients with
early and advanced cancer, and the results compared with those in healthy indi-
viduals, those with benign diseases and critically ill septic patients. The effect of
operation and local radiotherapy was determined on K cells. The initial values were
compared in those who subsequently lived or died to test their prognostic value.
K-cell activity was the same in women of all ages and was half that in men. It was
lower in men over 65 years than in younger men. In patients with early cancer, K-cell
activity was the same as in healthy individuals and those with benign diseases, and
was of no prognostic value. It was decreased by 42% in those with advanced cancer
but to the same extent as in the septic patients. Operation had no effect in those who
had normal activity before operation, but caused an 84% decrease in those who had
low preoperative values. The decrease was maximal at 5 days and recovery occurred
by 15 days. Radiotherapy caused a 72% decrease in K-cell activity, maximal at 5
weeks after starting treatment, with recovery by 16 weeks in those who had complete
tumour regression. The values remained low in those with persistent tumour or
metastases. The values during treatment did not help in identifying those who
subsequently lived or died.
THERE HAS BEEN considerable interest
in the prognostic value for survival of
tests for number and function of thymus-
dependent lymphocytes (T cells) and
bursa-dependent lymphocytes (B cells) in
cancer patients (Eilber & Morton, 1970;
Jerrells et al., 1978). It has generally been
found that they are normal in patients
with early cancer, and that they have no
prognostic value. The values are usually
decreased in those with advanced disease
(Takasugi et al., 1977).
Additional families of lymphocytes
have been recognized, such as antibody-
dependent cellular cytotoxicity (ADCC)
"killer" cells (K cells) which attack target
cells in the presence of antibodies specific
for the target cells (Moller, 1965; Perlmann
et al., 1972; MacLennan, 1972) and
"natural killer" cells (NK cells) which
attack cells in the absence of specific anti-
body (Herberman & Holden, 1978; Kiess-
ling & Haller, 1978). Unlike T and B cells,
K and NK cells are non-immune cells, in
that they do not require previous exposure
to the target cell. ADCC is mediated by
various populations of cells in the periph-
eral blood. When the target cell is nucle-
ated the ADCC is mediated exclusively by
K lymphocytes (MacDonald et al., 1975).
K cells are not T cells since they do not
form rosettes with sheep erythrocytes and
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are not B cells in that they do not have
surface immunoglobulins (Perlmann et al.,
1972). They were thought not to have
markers on their surface and were called
"null cells", but they have Fc receptors
which interact with the specific IgG
immunoglobulin on the surface of the
target cell.
We have determined K-cell activity of
peripheral-blood lymphocytes in patients
with early and advanced cancer, before
and after operation, and before, during
and after radiotherapy.
The values have been compared with
those in healthy controls, patients with
benign diseases and those critically ill with
systemic sepsis. The initial values in
patients with early cancer have been
compared with those who subsequently
lived or died to test their prognostic
value. Preliminary results concerning K
cell activity in normal and cancer patients
and for the effect of operation and radio-
therapy have been published (McCredie
et al., 1979b) as well as the effect of
systemic sepsis (McCredie et al., 1979a).
AIETHODS
The patients in this study wN-ere treated in
the London Clinic of the Ontario Cancer
T'reatment and Research Foundation, De-
partment of General Surgery and the Critical
Care/Trauma Unit, Victoria Hospital Corpor-
ation, London, Ontario.
The number of LMN cells/mm3 in the
peripheral blood of patients was obtained by
multiplying the total WtBC count by the
percentage of LMN cells in the differential
smear.
The test for antibody-dependent cellular
toxicity (ADCC) wNas performed as described
in detail previously (MacDonald et al., 1975).
Lymphocytes were isolated from the peri-
pheral blood by collecting a 10ml sample in
a heparinized tube, diluting with the same
volume of isotonic saline, layering on Ficoll-
Hypaque, centrifuging for 15 min at 1600
rev/min and removing the lymphocyte layer.
The suspensions were 95-100% viable, as
determined by trypan-blue exclusion, and
consisted of 90(o lymphocytes, 5oo mono-
cytes, and less than 500 polymorphonuclear
leucocytes. TIo avoid conifusion, the cell popu-
lations will subsequentlv be referred to as
lymphomononuclear (LMN) leucocytes. The
target cells wNrere P-815 mastocytoma cells
carried in ascitic form in DBA/2 mice (from
.Jackson Laboratories, Bar Harbour, Maine).
The mastocytoma cells 'were incubated with
200 jtCi sodium (51Cr) chromate (Na2 51CrO4)
for 45 min at 37°C and -washed x 3. Rabbit
anti-mastocytoma cell antibody was pre-
pared by injecting a rabbit i.v. w-ith 4 x 108
tumour cells monthly for 7 months. Serum
-was collected and heat-inactivated. The test
was performed in a total volume of 0-6 ml in
round-bottomed 10 x 65 mum plastic tubes
(Luckham Ltd, Surrey) and each procedure
wzas performed in duplicate. Labelled masto-
cytoma cells, 10,000 in 0-2 ml Modified
Eagle's Medium (MEM, GIBCO, Grand
Island, N.Y., U.S.A.) containing 500 (v/v)
foetal calf serum, were added to each tube.
Antibody, 0-2 ml at a dilution of 1:10,000,
was added to appropriate tubes and peri-
pheral-blood lymphocytes (also in 0-2 ml
medium) -were added to tubes either diluted
(5 x 106/ml) or at dilutions of 1: 3, 1: 10, 1: 30
or 1: 100. Medium wAas added to control tubes
to bring the volume to 0-6 ml. After incuba-
tion for 3 h at 37°C, the tubes mere centri-
fuged (500 g for 5 min) and isotope release
wA-as determined in the supernate using a well-
type scintillation counter (Nuclear-Chicago
Corporation).
Lysis was calculated as:
°0 specific 5lCr release=
experimental release-spontaneous release
_~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~6 maximal release- spontaneous release
x 100
Sponitaneous release was determined from the
tubes containing mastocytoma cells and
medium or antibody or lymphocytes. Maxi-
mal release was the value in the supernate in
tubes containing mastocytoma cells and 0-2
ml of IN HCI acid. The number of lympho-
cytes required to lyse 5000 of 10,000 masto-
cytoma target cells was defined as 1 lytic unit
(Cerottini et al., 1]974). An increase in lympho-
cytes per lytic unit signified a decrease in the
number of mastocytoma cells lysed by a
given number of lymphocytes. Results were
therefore expressed as lytic units per 106
lymphocytes, an increase in value signifying
an increase in ADCC activity.
Treatment of cancer often causes lympho-
penia. To allow for the lymphopenia frequent
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in cancer patients, the number of lytic units
per 106 cells was multiplied by the proportion
of LMN cells to total WBC in blood. The
results were expressed as lytic units per 106
cells per ml of blood (McCredie et al., 1979b).
Using this method of normalization, varia-
tions in the composition of the LMN suspen-
sions are unimportant.
Student's t test was used for the statistical
analysis. A probability of less than 5% was
accepted as significant.
RESULTS
Controls were 93 healthy individuals,
20 patients with benign diseases such as
peptic ulcer, hernia, cholecystitis and
reflux oesophagitis and 34 critically ill
septic patients admitted to the Critical
Care-Trauma Unit. There were 60 cancer
patients who were treated for cure, and 24
with advanced disease. The effect of
operation was stud
treated by cholecysi
herniorrhaphy and pe
results were combined
without cancer, bec<
had been shown to I
groups. Attempted ci
was given to 43 pati
of the breast, lung,
phagus.
The number of
TABLE. Number of 1
activity in men
over 65 years
LMN cells
(No./mm3 blood + s.e.)
Males
Females
K-cell activity
(lytic units x 106
cells/ml + s.e.)
Males
Females
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ied in 24 patients peripheral blood of healthy controls was
tectomy, vagotomy, the same in males and females aged 18-64
irtial colectomy. The years (Table). It then decreased but sig-
I in patients with and nificantly only in men. In healthy males,
ause K-cell activity K-cell activity was constant from 18-64
be the same in both years and decreased by 410% in older men.
urative radiotherapy In women, the values were constant with
ents with carcinomna age, and were 4900 lower than in men
rectum and oeso- under 65 years (P < 0.01).
The number of LMN cells was the same
LMN cells in the in healthy individuals, non-septic patients
with benign diseases and in those with
early cancer (Fig. 1). In the cancer ,MNcelln and K-cell patients, there was no difference in the
di women under and initial values between those who subse-
quently lived and those who died. In those
Under Over with advanced cancer, the number of 65 years 65 years LMN cells was 45% lower than in those
with early cancers (P< 0.02). This de-
'345+ 133* 1728+ 150* crease was similar to that in critically ill
(41) (13) septic patients who later died. The initial 059+97 1662+ 108 value for all the septic patients was not
(33) (19) significantly decreased, but was decreased
in those who subsequently died. The
initial LMN count in septic patients 9(4+1)3**t 113)29** indicated which patients would subse-
9.9+1.7t 10 6+2.4 quently live or die. In patients with early (33) (19) cancer, ADCC was similar to that in
*P<0o01; **p<0.05; healthy individuals and in those with
benign diseases. The values in individual
2
2
Probability diff. (t test)
tP>0.oJ.
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Fia. 2. The effects of operation on the number of lymphomononuclear cells and K-cell activity of
peripheral-blood lymphocytes are shown in patients with and without decreased preoperative
values (mean+s.e.). Normal immunity (15): x x K cells, x --- x LMN cells. Immuno-
depressed (9): * * K cells, 0 --- 0 LMN cells.
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cancer patients being treated for cure did
not predict later recurrence of disease.
Patients with advanced cancer had a
decrease in ADCC similar to that in
critically ill septic patients who later died.
The initial value in the septic patient did
not identify those patients who would
subsequently live or die.
The effect of operation was the same in
patients with benign disease and in
patients having attempted curative opera-
tions for cancer. The results were there-
fore combined. Operation did not signifi-
cantly affect the number of LMN cells
(Fig. 2). However, in patients with a 25%
decrease in the number of LMN cells pre-
operatively, there was a 4300 decrease at
5 days (P < 0.01) with return to the pre-
operative value at 15 days. One day after
operation, there was a 4300 decrease in
K-cell activity, followed by a rapid return
to normal. The decrease at one day was
not significant because of the wide disper-
sion in the preoperative values. In patients
with low K-cell activity before operation,
there was a 7200 decrease at 5 days
(P < 0 01) with return to the preoperative
value at 15 days.
Radiotherapy decreased the number of
I
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FIG. 3.- The effects of local radiotherapy on
the number of lymphomononuclear cells
and K-cell activity of peripheral-blood
lymphocytes in patients who survived or
subsequently developed recurrence of
tumour or metastasis. F- Survived;E Die(i.
LMN cells at 2 weeks after starting treat-
ment, with slow recovery after 5 weeks
(Fig. 3). The values were still low in many
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patients at 16 weeks. At no time was there
a significant difference between those who
subsequently lived and those who died.
Radiotherapy reduced K-cell activity,
with the nadir at 5 weeks after starting
treatment (P<0.01). The values slowly
returned to normal by 16 weeks in those
without persistence ofthe primary tumour
or distant metastases but remained low in
those with residual tumour (P< 0.05). The
decrease was most marked in those given
prophylactic postoperative radiotherapy
for carcinoma of the breast. The values
before radiotherapy or during treatment
did not help in predicting late recurrence
oftumour.
DISCUSSION
K-cell activity was normal in cancer
patients who were treated for cure and
did not differ in those who subsequently
lived and died. The values were decreased
in those with advanced cancer but to the
same extent as in those who were critically
ill with systemic sepsis. The decrease was
therefore not specific for cancer, and its
significance is not known. The common
factor may be the marked tissue catabo-
lism, mainly involving voluntary muscle,
seen in both conditions. These results are
in agreement with an earlier report from
our department (McCredie et al., 1979b).
Operation caused a decrease in K-cell
activity which was maximal at 5 days
with recovery by 15 days in patients who
were immunodepressed before operation.
The stress of the operation, anaesthetics
and drugs had had no significant effect on
K-cell activity in normal individuals.
Radiotherapy caused a marked decrease
in K-cell activity which was maximal at
5 weeks after starting treatment, with
recovery by 16 weeks in those who had
complete tumour regression and no distant
metastasis. Earlier values, however, were
useless. It was interesting that recovery
occurred at 2 weeks after operation in
those with low preoperative values and at
16 weeks after radiotherapy in those with
complete tumour regression. Recovery of
K-cell activity may occur within 2 weeks
after operation via metabolic activation or
short-term proliferation of K cells. Radio-
therapy, however, may permanently im-
pair K-cell function, or kill these cells.
Their replacement from more immature
precursor cells may be slow. The site of
formation and the generation time of K
cells in vivo are not known. Stratton et al.
(1977) observed an increase in K-cell
activity after radiotherapy. This may have
been the result of observing the patients
more than 16 weeks after treatment, at a
time when there may have been an
"overshoot" in K cell activity. Campbell
et al. (1976) found that radiotherapy
caused a decrease in T, B and K cells,
with recovery of B and K cells within 13
weeks but later recovery of T cells.
The significance of a decrease in ADCC
is not known, nor is it known whether
efforts to prevent or correct the decrease
is ofvalue to the patient. Our preliminary
results show that central hyperalimenta-
tion improves T-cell activity, but has
little effect on humoral immunity (Ota
et al., 1979).
A decrease in LMN cell count generally
occurred at the same time as a decrease in
K-cell activity. A decrease in lytic units of
K-cell activity represented an increase in
the ratio of lymphocytes to target cells
required to lyse 50% of 106 target cells. A
correction was therefore made for any
decrease in LMN cells, by multiplying the
number of lytic units by the ratio of the
LMN cells to the total WBC. When this
correction was made, the decrease in
K-cell activity therefore represented a
true selective decrease rather than a
simple consequence of lymphopenia. The
K-cell test cannot distinguish between a
decrease in the number of K cells and in
the activity of individual K cells, because
it is done at the level of the whole popu-
lation.
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